Global Tyrosine Kinase Inhibitors Market by Type (BCR-ABL, Epidermal Growth Factor Receptor, Vascular Endothelial Growth Factor Receptor), Application (Breast Cancer, Chronic Myeloid Leukemia, Lung Cancer), End-Users - Forecast 2024-2030- Product Image

Sale

Global Tyrosine Kinase Inhibitors Market by Type (BCR-ABL, Epidermal Growth Factor Receptor, Vascular Endothelial Growth Factor Receptor), Application (Breast Cancer, Chronic Myeloid Leukemia, Lung Cancer), End-Users - Forecast 2024-2030

Report
181 Pages
March 2024
Region: Global
360iResearch™
ID: 5715482

UP TO €850EUR$875USD£733GBP OFF until Dec 31^st 2024

The Tyrosine Kinase Inhibitors Market size was estimated at USD 59.07 billion in 2023, USD 63.46 billion in 2024, and is expected to grow at a CAGR of 7.17% to reach USD 95.95 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tyrosine Kinase Inhibitors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tyrosine Kinase Inhibitors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tyrosine Kinase Inhibitors Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International, Bristol-Myers Squibb Company, Cipla Limited, Eisai Co. Ltd., Eli Lilly and Company , F. Hoffmann-La Roche, GlaxoSmithKline PLC, Jiangsu Hansoh Pharmaceutical Group Co., Ltd., Johnson & Johnson Services, Inc., Lupin Limited, Novartis AG, Pfizer Inc., Spectrum Pharmaceuticals , Inc., Steris Healthcare Pvt. Ltd., and Takeda Pharmaceutical Company Limited .

Market Segmentation & Coverage

This research report categorizes the Tyrosine Kinase Inhibitors Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- BCR-ABL
- Epidermal Growth Factor Receptor
- Vascular Endothelial Growth Factor Receptor
Application
- Breast Cancer
- Chronic Myeloid Leukemia
- Lung Cancer
- Renal Cell Cancer
End-Users
- Homecare
- Hospitals
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Tyrosine Kinase Inhibitors Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tyrosine Kinase Inhibitors Market?
What are the technology trends and regulatory frameworks in the Tyrosine Kinase Inhibitors Market?
What is the market share of the leading vendors in the Tyrosine Kinase Inhibitors Market?
Which modes and strategic moves are suitable for entering the Tyrosine Kinase Inhibitors Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Tyrosine Kinase Inhibitors Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cancer and increasing adoption of targeted therapy
5.1.1.2. Improved use of natural tyrosine kinase inhibitors in medical formulations
5.1.2. Restraints
5.1.2.1. Limitations associated with resistance development and formulation interactions
5.1.3. Opportunities
5.1.3.1. Ongoing research activities to improve the quality of tyrosine kinase inhibitors
5.1.3.2. Favorable government approvals for Tyrosine Kinase Inhibitors
5.1.4. Challenges
5.1.4.1. Concerns associated with hepatotoxicity of tyrosine kinase inhibitors
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Tyrosine Kinase Inhibitors Market, by Type

6.1. Introduction
6.2. BCR-ABL
6.3. Epidermal Growth Factor Receptor
6.4. Vascular Endothelial Growth Factor Receptor

7. Tyrosine Kinase Inhibitors Market, by Application

7.1. Introduction
7.2. Breast Cancer
7.3. Chronic Myeloid Leukemia
7.4. Lung Cancer
7.5. Renal Cell Cancer

8. Tyrosine Kinase Inhibitors Market, by End-Users

8.1. Introduction
8.2. Homecare
8.3. Hospitals
8.4. Specialty Clinics

9. Americas Tyrosine Kinase Inhibitors Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Tyrosine Kinase Inhibitors Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Tyrosine Kinase Inhibitors Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. AstraZeneca PLC
13.1.2. Bayer AG
13.1.3. Boehringer Ingelheim International
13.1.4. Bristol-Myers Squibb Company
13.1.5. Cipla Limited
13.1.6. Eisai Co. Ltd.
13.1.7. Eli Lilly and Company ?
13.1.8. F. Hoffmann-La Roche
13.1.9. GlaxoSmithKline PLC
13.1.10. Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
13.1.11. Johnson & Johnson Services, Inc.
13.1.12. Lupin Limited
13.1.13. Novartis AG
13.1.14. Pfizer Inc.
13.1.15. Spectrum Pharmaceuticals , Inc.
13.1.16. Steris Healthcare Pvt. Ltd.
13.1.17. Takeda Pharmaceutical Company Limited ?
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. TYROSINE KINASE INHIBITORS MARKET RESEARCH PROCESS
FIGURE 2. TYROSINE KINASE INHIBITORS MARKET SIZE, 2023 VS 2030
FIGURE 3. TYROSINE KINASE INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TYROSINE KINASE INHIBITORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TYROSINE KINASE INHIBITORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TYROSINE KINASE INHIBITORS MARKET DYNAMICS
FIGURE 7. TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TYROSINE KINASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS TYROSINE KINASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TYROSINE KINASE INHIBITORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES TYROSINE KINASE INHIBITORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TYROSINE KINASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TYROSINE KINASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TYROSINE KINASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TYROSINE KINASE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. TYROSINE KINASE INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. TYROSINE KINASE INHIBITORS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. TYROSINE KINASE INHIBITORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. TYROSINE KINASE INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TYROSINE KINASE INHIBITORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. TYROSINE KINASE INHIBITORS MARKET SIZE, BY BCR-ABL, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TYROSINE KINASE INHIBITORS MARKET SIZE, BY EPIDERMAL GROWTH FACTOR RECEPTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TYROSINE KINASE INHIBITORS MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. TYROSINE KINASE INHIBITORS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TYROSINE KINASE INHIBITORS MARKET SIZE, BY CHRONIC MYELOID LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. TYROSINE KINASE INHIBITORS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TYROSINE KINASE INHIBITORS MARKET SIZE, BY RENAL CELL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 15. TYROSINE KINASE INHIBITORS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TYROSINE KINASE INHIBITORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. TYROSINE KINASE INHIBITORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS TYROSINE KINASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 28. CANADA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 31. MEXICO TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES TYROSINE KINASE INHIBITORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC TYROSINE KINASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 45. CHINA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 48. INDIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 54. JAPAN TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 72. THAILAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA TYROSINE KINASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. DENMARK TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 85. EGYPT TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 88. FINLAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 91. FRANCE TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 94. GERMANY TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 100. ITALY TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 109. NORWAY TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 112. POLAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 115. QATAR TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 136. TURKEY TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM TYROSINE KINASE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM TYROSINE KINASE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM TYROSINE KINASE INHIBITORS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 145. TYROSINE KINASE INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. TYROSINE KINASE INHIBITORS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. TYROSINE KINASE INHIBITORS MARKET LICENSE & PRICING

Companies Mentioned

AstraZeneca PLC
Bayer AG
Boehringer Ingelheim International
Bristol-Myers Squibb Company
Cipla Limited
Eisai Co. Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche
GlaxoSmithKline PLC
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Johnson & Johnson Services, Inc.
Lupin Limited
Novartis AG
Pfizer Inc.
Spectrum Pharmaceuticals , Inc.
Steris Healthcare Pvt. Ltd.
Takeda Pharmaceutical Company Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	181
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 63.46 Billion
Forecasted Market Value ( USD ) by 2030	$ 95.95 Billion
Compound Annual Growth Rate	7.1%
Regions Covered	Global
No. of Companies Mentioned	17

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,827GBP €3641EUR$3,749USD£3,141GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,581GBP €4613EUR$4,749USD£3,979GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,335GBP €5584EUR$5,749USD£4,817GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5900EUR$6,074USD£5,089GBP €6555EUR$6,749USD£5,655GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,598GBP €8498EUR$8,749USD£7,331GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Tyrosine Kinase Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2030

Tyrosine Kinase Inhibitors - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Tyrosine Kinase Inhibitors Global Market Report 2024

Tyrosine Kinase Inhibitor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Tyrosine Kinase Inhibitors: Global Market Outlook